课题基金 / 基金详情

Glycolipid Presentation by CD1d

Glycolipid Presentation by CD1d
CD1d 的糖脂介绍
批准号:
7010023
负责人:
ALBERT S. BENDELAC
金额:
$102.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-15 至 2007-12-31

项目摘要

项目成果

ALBERT S. BENDELAC的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):糖基神经酰胺作为CD1呈递的T细胞抗原具有重要的免疫功能,CD1是脂质结合mhc样分子家族。例如,α -半乳糖神经酰胺(alphaGC)特异性激活调节性NKT细胞,其通过释放Th1或Th2细胞因子来调节各种疾病状况。其他糖基神经酰胺可能引起参与多发性硬化症的适应性T细胞反应。因此,本项目以糖基神经酰胺为模型抗原家族,研究具有潜在临床应用价值的CD1d分子递呈糖脂抗原的基本问题。
英文摘要
DESCRIPTION (provided by applicant): Glycosylceramides perform important immunological functions as T cell antigens presented by CD1, a family of lipid-binding MHC-like molecules. For example, an alpha-galactosylceramide (alphaGC) specifically activates regulatory NKT cells, which modulate, through the release of either Th1 or Th2 cytokines, various disease conditions. Other glycosylceramides may elicit adaptive T cell responses involved in Multiple Sclerosis. Thus, the program project uses glycosylceramides as a model antigen family to study fundamental issues of glycolipid antigen presentation by CD1d molecules with potential clinical applications. A multidisciplinary approach encompassing glycolipid synthetic chemistry, protein expression, biophysics and structural biology, as well as cellular immunology and cell biology, has been assembled. Synthetic variants of alphaGC, the NKT cell antigen, will be generated to study the structural determinants of their adjuvant properties. We will use new approaches to visualize the cellular uptake and trafficking, CD1 loading and TCR binding of glycosylceramides and will search for new variants with selective Th1 or Th2 adjuvant properties modulating expression of diseases such as type I diabetes, experimental encephalomyelitis and cancer. In addition to the innate NKT cell response to alphaGC, we also will probe the diversity and specificity of the glycolipid-specific adaptive TCR repertoire, a prerequisite to design glycolipid-specific T cell vaccines. The individual research projects are as follows. Project 1, Savage: Design of alphaGC structural variants with selective Th1 or Th2 properties. Project 2, Teyton: Biophysical and structural aspects of glycosylceramide interaction with CD1d and TCR. Project 3, Bendelac: T cell repertoire and functions associated with glycosylceramide recognition in vivo in mice and intracellular trafficking properties of glycosylceramides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional Regulation of Innate-Like T Cells
  • 批准号:
    10441712
  • 项目类别:
  • 资助金额:
    $53.32万
  • 财政年份:
    2022
  • 负责人:
    ALBERT S. BENDELAC
  • 依托单位:
Development of Intestinal Polyreactive IgA B Cells
  • 批准号:
    10543053
  • 项目类别:
  • 资助金额:
    $49.84万
  • 财政年份:
    2019
  • 负责人:
    ALBERT S. BENDELAC
  • 依托单位:
Development of Intestinal Polyreactive IgA B Cells
  • 批准号:
    10321246
  • 项目类别:
  • 资助金额:
    $49.84万
  • 财政年份:
    2019
  • 负责人:
    ALBERT S. BENDELAC
  • 依托单位:
Development of Intestinal Polyreactive IgA B Cells
  • 批准号:
    10078246
  • 项目类别:
  • 资助金额:
    $49.84万
  • 财政年份:
    2019
  • 负责人:
    ALBERT S. BENDELAC
  • 依托单位:
海外基金